PRAXIS PRECISION MEDICINES, INC. Shareholders' Equity
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Shareholders' Equity of $1.34 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.34B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.41B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $878.14M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $343.50M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.34B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.41B 10-Q · filed 2026-08-06 |
| 2025-12-31 | $878.14M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $343.50M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $404.22M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $439.21M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $445.45M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $382.67M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $419.10M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $229.68M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $69.67M 10-K · filed 2026-02-19 |
| 2023-09-30 | $86.76M 10-K · filed 2025-02-28 |
| 2023-06-30 | $105.63M 10-K · filed 2025-02-28 |
| 2023-03-31 | $64.47M 10-K · filed 2025-02-28 |
| 2022-12-31 | $76.11M 10-K · filed 2026-02-19 |
| 2022-09-30 | $105.16M 10-K · filed 2024-03-05 |
| 2022-06-30 | $138.87M 10-K · filed 2024-03-05 |
| 2022-03-31 | $191.02M 10-K · filed 2024-03-05 |
| 2021-12-31 | $250.81M 10-K · filed 2024-03-05 |
| 2021-09-30 | $295.92M 10-K · filed 2023-02-07 |
| 2021-06-30 | $333.77M 10-K · filed 2023-02-07 |
| 2021-03-31 | $265.51M 10-K · filed 2023-02-07 |
| 2020-12-31 | $287.46M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$123.26M 10-K · filed 2022-02-28 |
| 2020-06-30 | -$104.08M 10-K · filed 2022-02-28 |
| 2020-03-31 | -$90.76M 10-K · filed 2022-02-28 |
| 2019-12-31 | -$81.01M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$72.06M 10-Q · filed 2020-11-23 |
| 2019-06-30 | -$60.46M 10-Q · filed 2020-11-23 |
| 2018-12-31 | -$41.04M 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |